Featured Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues Despite some COVID-19 setbacks in this phase IIb dose-finding study of trientine HCL, the PI thinks it’s worth moving forward. By Shelley Wood May 25, 2023